David A Hutton

6PUBLICATIONS
15CO-AUTHORS
Molecular targetsEvolutionary impacts of climate changeHaematological tumoursEvolution of developmental systemsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 27, 2025
Cellular senescence mediates doxorubicin chemotherapy-induced vascular endothelial dysfunction: translational evidence of prevention with senolytic treatment.

Ravinandan Venkatasubramanian, Sophia A Mahoney, David A Hutton

|Aug 01, 2025
Cellular Senescence Mediates Doxorubicin Chemotherapy-Induced Aortic Stiffening: Role of Glycation Stress.

Ravinandan Venkatasubramanian, Mary A Darrah, Sophia A Mahoney

|Aug 18, 2023
Cellular Senescence Contributes to Large Elastic Artery Stiffening and Endothelial Dysfunction With Aging: Amelioration With Senolytic Treatment.

Zachary S Clayton, Matthew J Rossman, Sophia A Mahoney

|Sep 16, 2022
Initiation of 3,3-dimethyl-1-butanol at midlife prevents endothelial dysfunction and attenuates in vivo aortic stiffening with ageing in mice.

Abigail G Casso, Nicholas S VanDongen, Rachel A Gioscia-Ryan

|Jun 11, 2021
Apigenin restores endothelial function by ameliorating oxidative stress, reverses aortic stiffening, and mitigates vascular inflammation with aging.

Zachary S Clayton, David A Hutton, Vienna E Brunt

|Jul 13, 2019
Physical activity-related suppression of cancer growth: is a transient increase in cytokine production required for tumour angiogenesis?

David A Hutton, Zachary S Clayton

Pageof 1

Frequent Collaborators

6 joint publications

Zachary S Clayton

5 joint publications

Vienna E Brunt

5 joint publications

Douglas R Seals

4 joint publications

Abigail G Longtine